NCT06739252 2026-01-28
Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA
Peking University
Phase 2 Terminated
Clinical Trials
1 trialsCirrhosis, Familial, with Pulmonary Hypertension × gemcitabine-oxaliplatin regimen × 90 days × Clear all